---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-23-000015"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T07:59:02.867654+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lexicon shareholders approve amendment to increase equity plan shares to 55M

## Summary
- Stockholders approved amendment to 2017 Equity Incentive Plan, increasing authorized shares from 30,000,000 to 55,000,000.
- Amendment to 2017 Non-Employee Directors' Equity Incentive Plan increased share reserve from 1,200,000 to 2,000,000.
- Voting results: For: 110,232,367; Against: 24,746,403; Abstain: 16,261,356; Broker non-votes: 13,664,122.
- Amendments adopted by Board on Feb 9, 2023 and approved at annual meeting on April 27, 2023.

## SEC filing metadata
- accession: 0001062822-23-000015
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/lxrx-20230427.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-23-000015
- JSON: https://secwatch.observer/filing/0001062822-23-000015.json
- Plain text: https://secwatch.observer/filing/0001062822-23-000015.txt

## Key facts
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Advisory vote to determine the frequency of future advisory votes on the compensation paid to our named executive officers at the 2023-04-27 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: Advisory vote to determine the frequency of future advisory votes on the compensation paid to our named executive officers 133,664,598 143,970 949,241 16,482,317
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Election of Class II Directors at the 2023-04-27 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: Election of Class II Directors Name of Director For Withheld Broker Non-Votes Samuel L. Barker, Ph.D. 142,120,279 9,119,847 13,664,122 Christopher J. Sobecki 143,104,310 8,135,816 13,664,122 Judith L. Swain, M.D. 135,882,215 15,357,911 13,664,122
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the amendment to the Company’s 2017 Non-Employee Directors’ Equity Incentive Plan at the 2023-04-27 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: Ratification and approval of the amendment to the Company’s 2017 Non-Employee Directors’ Equity Incentive Plan 132,867,426 2,097,598 16,275,102 13,664,122
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Advisory vote to approve the compensation paid to the Company’s named executive officers at the 2023-04-27 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: Advisory vote to approve the compensation paid to the Company’s named executive officers 110,285,867 24,701,050 16,253,209
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the amendment to the Company’s 2017 Equity Incentive Plan at the 2023-04-27 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: Ratification and approval of the amendment to the Company’s 2017 Equity Incentive Plan 110,232,367 24,746,403 16,261,356 13,664,122
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm
- Shareholder Votes
  LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2023 at the 2023-04-27 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-04-27
  source text: Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2023 146,680,955 725,184 17,498,109
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282223000015/0001062822-23-000015-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.